Nephros Inc
NASDAQ:NEPH
Nephros Inc
Total Equity
Nephros Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nephros Inc
NASDAQ:NEPH
|
Total Equity
$10m
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
|
Whirlpool Corp
NYSE:WHR
|
Total Equity
$2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Hamilton Beach Brands Holding Co
NYSE:HBB
|
Total Equity
$182.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Cricut Inc
NASDAQ:CRCT
|
Total Equity
$343.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Vesync Co Ltd
HKEX:2148
|
Total Equity
$369.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
86%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sharkninja Inc
NYSE:SN
|
Total Equity
$2.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nephros Inc
Glance View
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
See Also
What is Nephros Inc's Total Equity?
Total Equity
10m
USD
Based on the financial report for Sep 30, 2025, Nephros Inc's Total Equity amounts to 10m USD.
What is Nephros Inc's Total Equity growth rate?
Total Equity CAGR 10Y
14%
Over the last year, the Total Equity growth was 22%. The average annual Total Equity growth rates for Nephros Inc have been 17% over the past three years , 4% over the past five years , and 14% over the past ten years .
